Skip to main content

Table 3 Estimates of prevalence of central obesity defined by the ATP III and the IDF criteria among iranian adults 25–64 years old

From: Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia

  High WC by IDFa High WC by ATPIII
  National
estimateb
Prevalence
(95% CI)
National
estimateb
Prevalence
(95% CI)
Age     
   25–34 (n = 1081) 5.0 39.3 (34.2–44.6) 2.7 21.5 (17.5–26.1)
   35–44 (n = 1113) 5.3 58.7 (53.7–63.5) 3.3 37.5 (31.8–43.5)
   45–54 (n = 1069) 4.2 66.7 (61.2–71.8) 2.9 45.5 (39.0–52.2)
   55–64 (n = 970) 2.3 70.0 (64.7–74.7) 1.7 49.5 (42.6–56.5)
Sex     
   Males (n = 2121) 5.5 34.4 (31.3–37.5) 2.2 13.9 (11.9–16.0)
   Females (n = 2112) 1.1 73.4 (69.5–77.0) 8.4 54.4 (50.0–58.8)
Residential area     
   Urban (n = 2853) 12.6 56.0 (52.5–59.5) 8.0 35.5 (32.0–39.1)
   Rural (n = 1380) 4.2 47.5 (40.7–54.4) 2.7 29.8 (23.8–36.5)
Total national estimate
(n = 4233)
16.8 53.6 (50.4–56.8) 10.6 33.8 (30.8–37.1)
  1. WC: waist circumference, CI: confidence interval
  2. a ATP III: Third Adult Treatment Panel; IDF: International Diabetes Federation
  3. b Rounded to the nearest million
  4. Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006